Blastomycosis in Dogs: Symptoms, Diagnosis, Treatment & Prognosis
Complete guide to blastomycosis in dogs — learn symptoms by severity, diagnostic tests, treatment costs, survival rates, and which breeds are most at risk.
Blastomycosis in dogs is a serious systemic fungal infection caused by inhaling spores of the Blastomyces dermatitidis organism (and the more recently identified Blastomyces gilchristii). This dimorphic fungus lives in moist, acidic soil rich in organic debris — particularly near waterways, riverbanks, and wooded areas across the Mississippi, Ohio, and Missouri River valleys, the Mid-Atlantic states, and parts of the Pacific Northwest. According to the Merck Veterinary Manual, dogs are 6 to 10 times more likely than humans to contract blastomycosis, making them effective sentinels for environmental contamination. Infection rates peak in late summer and early fall when soil disturbance releases spores into the air, though cases occur year-round. Once inhaled, the spores transform into yeast forms at body temperature and can disseminate through the bloodstream to the lungs, eyes, skin, bones, lymph nodes, and central nervous system. Approximately 65–85% of infected dogs show lung involvement at diagnosis, and untreated disseminated disease carries a poor prognosis. Early recognition is critical — this guide covers everything from first warning signs to treatment costs so you can act decisively.
What Is Blastomycosis in Dogs and How Does Infection Occur?
Blastomycosis is a deep fungal infection — not contagious from dog to dog or dog to human. The infection cycle begins when a dog disturbs contaminated soil during normal activities: digging, sniffing along creek beds, playing in leaf litter, or exploring construction sites. The microscopic spores (2–5 micrometers) are inhaled into the terminal airways, where they convert to the pathogenic yeast form within 24–48 hours.
The yeast organisms evade the immune system through a thick, refractile cell wall that resists phagocytosis. From the lungs, the infection can remain localized or spread hematogenously (through the blood) to secondary sites. The typical incubation period ranges from 3 weeks to 4 months, though some dogs may show signs within 1 week of heavy exposure.
Geographic clustering is a defining feature of blastomycosis. States with the highest incidence include Wisconsin, Minnesota, Missouri, Illinois, Michigan, Indiana, Ohio, Kentucky, Tennessee, and parts of the Carolinas. However, cases have been reported in nearly every U.S. state, often linked to travel to endemic areas or localized environmental pockets near water.
Symptoms of Blastomycosis: Early Warning Signs vs. Advanced Disease
Blastomycosis is notoriously difficult to identify in its early stages because initial symptoms mimic common respiratory infections. The table below organizes clinical signs by severity to help you recognize when routine symptoms may signal something more serious.
| Severity Level | Clinical Signs | Typical Onset |
|---|---|---|
| Early / Mild | Dry, hacking cough; mild fever (102–103.5°F / 38.9–39.7°C); reduced appetite; lethargy; slight weight loss | Weeks 1–3 of clinical illness |
| Moderate / Progressive | Productive or moist cough; exercise intolerance; visible weight loss (5–10% body weight); skin lesions (raised, ulcerated, draining tracts); swollen lymph nodes; eye inflammation (uveitis, cloudiness) | Weeks 3–6 without treatment |
| Severe / Disseminated | Labored breathing (dyspnea); lameness from bone involvement; blindness or severe vision changes; neurological signs (seizures, head tilt, circling); anorexia; high fever (>104°F / 40°C); collapse | Weeks 6+ or rapid progression |
The most commonly affected organ systems and their approximate frequency at diagnosis include:
- Lungs: 65–85% of cases — diffuse interstitial or nodular patterns on chest radiographs
- Skin: 30–50% — multiple raised, crusty, or draining lesions, often on the face, nasal planum, and nail beds
- Eyes: 20–40% — uveitis, retinal detachment, glaucoma secondary to inflammation
- Bones: 10–30% — osteomyelitis causing lameness, most often in long bones
- Lymph nodes: 30–50% — generalized or regional lymphadenopathy
- Central nervous system: 5–10% — granulomatous meningoencephalitis, typically late-stage
Risk Factors: Which Dogs Are Most Vulnerable?
Breed Predisposition
While any dog can contract blastomycosis, sporting and working breeds with high environmental exposure show disproportionate infection rates. Dogs that spend significant time outdoors in endemic areas — hunting, hiking, or working in fields and waterways — face the greatest risk. Breeds frequently overrepresented in clinical reports include:
- Labrador Retrievers
- Golden Retrievers
- Doberman Pinschers
- Treeing Walker Coonhounds and other coonhound breeds
- Pointers and Setters
Male dogs are diagnosed approximately 2 times more often than females, likely reflecting ranging behavior and environmental exposure rather than true genetic susceptibility.
Age and Immune Status
Dogs aged 2–4 years represent the peak incidence group, correlating with peak outdoor activity levels. However, blastomycosis occurs across all ages. Immunocompromised dogs — those on long-term corticosteroids, with Cushing's disease, or concurrent illness — may develop more severe disseminated disease.
Environmental and Geographic Factors
- Proximity to rivers, lakes, streams, or marshland (within 400 meters significantly increases risk)
- Soil disturbance activities: construction zones, freshly tilled land, logging areas
- Seasonal peaks: August through November in most endemic regions
- Acidic, sandy soil with high organic content and decaying wood matter
How Veterinarians Diagnose Blastomycosis in Dogs
Diagnosing blastomycosis requires a combination of clinical suspicion, imaging, and laboratory confirmation. Your veterinarian will typically follow a stepwise diagnostic process:
- Step 1 — Clinical History & Physical Exam ($80–$150): Your vet will assess travel history, outdoor exposure, geographic location, and perform a thorough physical exam noting lymph node size, skin lesions, respiratory sounds, and ocular changes.
- Step 2 — Thoracic Radiographs ($200–$400): Chest X-rays (typically 3 views) reveal characteristic patterns: diffuse interstitial to alveolar infiltrates, tracheobronchial lymphadenopathy, or nodular lung lesions. A "snowstorm" pattern is considered suggestive but not pathognomonic.
- Step 3 — Complete Blood Count & Chemistry Panel ($150–$300): Common findings include leukocytosis (elevated white blood cells), monocytosis, hypercalcemia (in 10–30% of cases due to granulomatous inflammation), hypoalbuminemia, and elevated globulins.
- Step 4 — Urine Antigen Test ($80–$150): The MiraVista Blastomyces antigen EIA is the most widely used rapid test. Sensitivity ranges from 85–93% for disseminated disease but drops to approximately 50–60% for pulmonary-only cases. Results typically return within 1–3 business days. Cross-reactivity with Histoplasma antigens can occur.
- Step 5 — Cytology or Biopsy ($200–$600): Fine-needle aspirates of affected lymph nodes, skin lesions, or lung tissue can reveal the characteristic broad-based budding yeast (8–25 micrometers with thick, double-contoured walls). Histopathology with PAS or GMS staining provides definitive confirmation.
- Step 6 — Advanced Imaging if Needed ($500–$1,200): CT scans may be recommended for complex cases involving bone, CNS, or when radiographs are inconclusive.
Total diagnostic costs typically range from $700 to $2,500 depending on disease complexity and whether referral to a specialty center is required.
Treatment Options: Antifungal Therapy and Supportive Care
Blastomycosis is treatable, and many dogs achieve full remission with appropriate antifungal therapy. Treatment duration is prolonged — typically 2 to 3 months minimum, and sometimes 6 months or longer for severe or disseminated cases. The goal is complete clinical resolution plus negative follow-up antigen testing.
| Medication | Typical Dosage | Duration | Monthly Cost (50 lb dog) | Notes |
|---|---|---|---|---|
| Itraconazole (preferred) | 5 mg/kg PO every 12 hours | 2–6 months | $150–$400 (generic) | First-line treatment; well-tolerated; give with fatty food for absorption; monitor liver enzymes every 4–6 weeks |
| Fluconazole | 5–10 mg/kg PO every 12 hours | 2–6 months | $100–$300 | Better CNS and ocular penetration; preferred when brain or eye involvement is suspected; lower overall efficacy for pulmonary disease |
| Amphotericin B (lipid complex) | 1–2 mg/kg IV 2–3× per week | 4–6 weeks, then switch to oral azole | $800–$2,000+ (hospital-based) | Reserved for severe, life-threatening cases; requires IV administration and hospitalization; nephrotoxic — renal values monitored closely |
| Combination therapy | Amphotericin B + itraconazole | Ampho B 2–4 weeks, then azole 3–6 months | $2,000–$5,000+ | Gold standard for severe disseminated disease; fastest clinical response; highest cost tier |
Supportive Care Measures
Beyond antifungal medication, comprehensive treatment often includes:
- Oxygen therapy: For dogs with severe pulmonary compromise; requires hospitalization ($100–$200/day)
- Anti-inflammatory medications: Short-course NSAIDs or corticosteroids to manage severe inflammatory response — particularly important during the first 1–2 weeks when dying organisms can trigger worsening inflammation (a Jarisch-Herxheimer-like reaction)
- Secondary infection management: Antibiotics for bacterial skin infections at draining lesion sites
- Nutritional support: High-calorie, easily digestible diet for dogs with significant weight loss; appetite stimulants (mirtazapine, capromorelin) if needed
- Ocular management: Topical anti-inflammatories and atropine for uveitis; referral to a veterinary ophthalmologist if retinal detachment or glaucoma develops
Can Blastomycosis Be Cured?
Yes — blastomycosis can be cured in the majority of dogs that receive timely treatment. Published cure rates for dogs treated with itraconazole alone range from 70–90% for mild to moderate pulmonary disease. For disseminated disease, overall survival rates with aggressive treatment fall to approximately 50–70%. Dogs with CNS involvement have the poorest prognosis, with survival rates below 30% even with treatment. Relapse occurs in approximately 10–20% of cases, typically within 3–6 months of completing therapy, which is why follow-up antigen monitoring is essential.
Prognosis by Disease Stage and Severity
| Disease Stage | Description | Estimated Survival Rate (with treatment) | Expected Treatment Duration |
|---|---|---|---|
| Mild / Pulmonary Only | Cough, mild fever, localized lung infiltrates on radiographs; no extrapulmonary spread | 85–95% | 2–3 months |
| Moderate / Limited Dissemination | Lung involvement plus 1–2 secondary sites (skin, lymph nodes); stable overall condition | 70–85% | 3–4 months |
| Severe / Multi-organ | Lungs plus 3+ organ systems; significant weight loss; labored breathing; multiple skin lesions | 40–60% | 4–6+ months |
| Critical / CNS or Severe Pulmonary | Neurological signs, severe respiratory distress, or hypoxemia requiring oxygen support | 20–40% | 6+ months if survived |
What Is the Life Expectancy of a Dog with Blastomycosis?
Dogs that survive the initial treatment period and achieve remission generally return to a normal life expectancy. Studies following treated dogs for 2+ years post-treatment show no long-term reduction in lifespan for animals that fully clear the infection. However, dogs with permanent organ damage — particularly vision loss from ocular blastomycosis or chronic lung scarring — may require ongoing management that affects quality of life. The critical window is the first 2–4 weeks of treatment: dogs that survive this period and show clinical improvement have a strong chance of full recovery.
Home Care and Daily Management During Treatment
Managing blastomycosis at home requires consistency, observation, and patience. Here is what daily care looks like during the treatment period:
Medication Administration
- Itraconazole must be given with a fatty meal for adequate absorption — mix the capsule contents or liquid formulation with canned food, peanut butter, or a small amount of cheese. Pulse-dosing protocols (one week on, one week off) are sometimes used to reduce cost and side effects, but only under veterinary direction.
- Administer doses at consistent 12-hour intervals. Missed doses reduce treatment efficacy and increase relapse risk.
- Store itraconazole capsules at room temperature; the liquid formulation may require refrigeration depending on compounding pharmacy instructions.
Monitoring at Home
- Track appetite daily — weigh food portions and note any refusal lasting more than 24 hours
- Monitor respiratory rate at rest: normal is 15–30 breaths per minute; sustained rates above 40 at rest warrant a vet call
- Photograph skin lesions weekly to document healing progression for your vet
- Watch for signs of drug toxicity: vomiting, diarrhea, yellowing of gums or eyes (icterus), dark urine — these may indicate liver stress from azole therapy
- Limit strenuous exercise during the first 4–6 weeks; short leash walks are appropriate, but avoid running, swimming, or hunting until cleared by your vet
Follow-Up Schedule
Expect recheck appointments every 3–4 weeks during active treatment, including:
- Repeat thoracic radiographs to assess lung clearance
- Serum chemistry panels to monitor liver function (ALT, ALP, bilirubin)
- Urine antigen testing every 4–6 weeks; treatment should continue until antigen levels are undetectable on two consecutive tests
- Complete blood count to assess inflammatory response resolution
Treatment Cost Breakdown: What to Budget
Blastomycosis treatment represents a significant financial commitment. The table below outlines realistic cost ranges based on 2025–2026 veterinary pricing across the United States. Costs vary by region, clinic type (general practice vs. specialty center), and disease severity.
| Cost Category | Mild Case | Moderate Case | Severe Case |
|---|---|---|---|
| Initial diagnostics (exam, X-rays, blood work, antigen test) | $600–$1,000 | $900–$1,800 | $1,500–$3,000 |
| Antifungal medication (total course) | $300–$800 | $600–$1,500 | $1,500–$4,000+ |
| Hospitalization (if required) | $0 | $500–$2,000 | $2,000–$8,000+ |
| Follow-up visits and monitoring (4–8 rechecks) | $400–$800 | $600–$1,200 | $1,000–$2,500 |
| Supportive care (oxygen, IV fluids, nutritional support) | $0–$200 | $300–$1,000 | $1,500–$5,000 |
| TOTAL ESTIMATED COST | $1,300–$2,800 | $2,900–$7,500 | $7,500–$22,500+ |
Pet insurance can significantly offset these costs if the policy was active before symptom onset. Most comprehensive plans (Trupanion, Healthy Paws, Nationwide) cover diagnostic testing and prescription antifungal therapy. Check your policy's annual limits — severe cases can approach or exceed $10,000, making high-limit or unlimited-coverage plans valuable in endemic regions.
When to See the Vet: Emergency Red Flags
🚨 Seek Immediate Veterinary Attention If Your Dog Shows:
- Severe difficulty breathing — open-mouth breathing, extended neck, blue-tinged gums (cyanosis)
- Acute collapse or inability to stand
- Seizures or acute neurological changes — head pressing, disorientation, sudden blindness
- Fever above 104.5°F (40.3°C) that doesn't respond to cooling measures
- Complete refusal to eat or drink for more than 24 hours during active treatment
- Yellowing of the gums, skin, or whites of the eyes — possible drug-induced liver injury
- Sudden worsening of cough or coughing up blood (hemoptysis) during treatment
Any of these signs may indicate disease progression, drug toxicity, or a life-threatening inflammatory response to dying fungal organisms. Emergency veterinary hospitals can provide oxygen supplementation, IV antifungal therapy, and intensive monitoring that general practice clinics cannot offer after hours.
Prevention: Reducing Your Dog's Risk of Blastomycosis
There is currently no commercially available vaccine for blastomycosis in dogs. Prevention relies entirely on exposure reduction, which is challenging for dogs that live in endemic regions and lead active outdoor lifestyles. Practical risk-reduction strategies include:
- Avoid high-risk environments during peak season: Limit your dog's access to riverbanks, marshy areas, and freshly disturbed soil from August through November in endemic states.
- Redirect digging behavior: Provide designated digging pits with clean sand away from organic-rich soil. Discourage digging near decaying wood, compost piles, or construction zones.
- Leash walks near waterways: Keep dogs on-leash when hiking near rivers and streams in known endemic areas to prevent extensive sniffing and digging in contaminated banks.
- Monitor construction and landscaping sites: Soil excavation releases concentrated spore clouds. Keep dogs away from active earth-moving projects in your neighborhood.
- Know the early symptoms: The most effective "prevention" is early detection. A persistent cough in an outdoor dog in an endemic region warrants fungal testing, not just another round of antibiotics.
Research into a recombinant Blastomyces vaccine is ongoing, with several candidate antigens showing promise in preclinical trials at the University of Wisconsin–Madison. However, a commercially licensed vaccine is not expected before 2027 at the earliest.
Frequently Asked Questions
Can humans get blastomycosis from their dogs?
No. Blastomycosis is not transmitted from animal to human or animal to animal. Both dogs and humans acquire the infection independently from the same environmental source — inhaling spores from contaminated soil. However, if your dog is diagnosed, it signals that your shared environment may harbor Blastomyces, and immunocompromised household members should be aware of potential exposure. The CDC provides guidance on human blastomycosis for concerned pet owners.
How long does it take for a dog to recover from blastomycosis?
Most dogs show noticeable clinical improvement within 1–2 weeks of starting antifungal therapy, but full treatment courses last a minimum of 60–90 days. Severe cases may require 4–6 months of continuous medication. Treatment should never be stopped based on clinical improvement alone — it must continue until follow-up urine antigen tests return negative results on two consecutive tests spaced 4–6 weeks apart.
Does pet insurance cover blastomycosis treatment?
Most comprehensive accident-and-illness pet insurance policies cover blastomycosis diagnosis and treatment, including diagnostics, medications, and hospitalization — provided the policy was active before symptoms first appeared. Pre-existing condition exclusions apply. If you live in an endemic area, securing coverage before any symptoms develop is strongly recommended. Annual maximums of $10,000 or higher (or unlimited) are advisable given potential treatment costs.
Can blastomycosis recur after successful treatment?
Yes. Relapse occurs in approximately 10–20% of treated dogs, most commonly within 3–6 months of completing therapy. Relapse rates are higher in dogs with severe initial disease, incomplete treatment courses, or inadequate follow-up monitoring. If relapse occurs, the same antifungal protocol is typically reinstated for an extended duration. Owners should remain vigilant for symptom recurrence for at least 12 months after treatment ends.
Is blastomycosis contagious to other pets in the household?
No. Blastomyces yeast forms in infected tissue do not produce infectious spores, so direct transmission between animals does not occur under normal circumstances. However, other pets in the household likely share the same environmental exposure and should be monitored for symptoms. Rarely, transmission has been reported via needlestick injury or bite wound inoculation in veterinary settings, but this is not a concern in typical household environments.
Are there regions where blastomycosis is expanding?
Yes. Recent surveillance data indicates Blastomyces is expanding beyond traditional endemic boundaries. Cases are increasingly reported in areas previously considered low-risk, including parts of the Northeast, the Gulf Coast, and the Pacific Northwest. Climate change, altered precipitation patterns, and increased land development are thought to contribute to this geographic expansion. The AVMA recommends that veterinarians maintain blastomycosis on their differential diagnosis list regardless of location if clinical signs are consistent and the dog has outdoor exposure.
The Bottom Line: Blastomycosis in dogs is a serious but treatable fungal disease. Early recognition of persistent respiratory symptoms, skin lesions, and systemic illness in outdoor dogs — particularly in endemic regions — is the single most important factor in achieving a positive outcome. If your dog fits the risk profile and shows any of the symptoms described above, don't wait for antibiotics to fail. Ask your veterinarian about fungal antigen testing. The Merck Veterinary Manual remains an excellent reference for ongoing education about this and other systemic mycoses.
Robin Maitland
All our authors care for dogs every day — read more of their work on the authors page.
